AbbVie Wins EU Approval for RINVOQ in Pediatric JIA
North Chicago, Illinois, U.S., September 22, 2026 AbbVie has announced that the European Commission has approved RINVOQ® (upadacitinib) for...
immunology
Advertisement
Johnson & Johnson Wins EU Approval for ICOTYDE in Psoriasis
Beerse, Belgium, September 21, 2026 Johnson & Johnson has reached a major European regulatory milestone with the European Commission’s...
Cue Biopharma Reports Positive Phase 2 CUE-221 Results
BOSTON — September 20, 2026 Cue Biopharma announced positive topline results from a Phase 2 study of CUE-221 (UB-221)...
Novartis Advances Cosentyx for Polymyalgia Rheumatica
Basel, Switzerland, September 18, 2026 Novartis has announced that the European Medicines Agency’s Committee for Medicinal Products for Human...
Insilico Opens AI Toolkit for Global Longevity Research
Abu Dhabi, UAE, September 17, 2026 Insilico Medicine has announced the global opening of its AI-powered longevity discovery toolkit,...
Advertisements
Inductive Bio Launches Beacon-2 for AI Drug Discovery
New York, New York, September 17, 2026 Inductive Bio has launched Beacon-2, a new artificial intelligence system designed to...
Aethlon Medical Merges With North Immunology for NOR-101
San Diego, California, and Austin, Texas, September 17, 2026 Aethlon Medical, Inc. and North Immunology, Inc. have announced a...
Novo Nordisk Denecimig Shows Tolerability in Hemophilia A
Plainsboro, New Jersey, and Bagsværd, Denmark, September 17, 2026 Novo Nordisk has announced published Phase 3b results from the...
Dualitas Therapeutics and Roche Launch $1B Bispecific Collaboration
SOUTH SAN FRANCISCO, Calif. — September 17, 2026 Dualitas Therapeutics announced a research collaboration and license agreement with Roche...
Bristol Myers Squibb Reports Durable Sotyktu Results in PsA
PRINCETON, N.J. — September 17, 2026 Bristol Myers Squibb announced positive two-year results from the Phase 3 POETYK PsA-2...
Advertisement
